海峡药学2024,Vol.36Issue(3) :95-98.

临床药师参与1例心力衰竭、心肌梗死合并房颤患者的药物治疗

The Clinical Pharmacist Participated in the Drug Treatment of a Patient with Heart Failure,Myocardial Infarction and Atrial Fibrillation

受国徽 苏会源 李波霞
海峡药学2024,Vol.36Issue(3) :95-98.

临床药师参与1例心力衰竭、心肌梗死合并房颤患者的药物治疗

The Clinical Pharmacist Participated in the Drug Treatment of a Patient with Heart Failure,Myocardial Infarction and Atrial Fibrillation

受国徽 1苏会源 2李波霞3
扫码查看

作者信息

  • 1. 天水市中西医结合医院,甘肃天水 741020
  • 2. 临夏回族自治州人民医院,甘肃临夏 731100
  • 3. 兰州大学第一医院,甘肃兰州 730000
  • 折叠

摘要

目的 梳理复杂治疗方案后的抗栓方案,重整抗栓药物和疗程,纠正不合理用药,促进合理用药.方法 临床药师介入1 例心力衰竭、多次因心肌梗死植入多枚支架,合并房颤,行射频消融和左心耳封堵患者的药物治疗,重整抗栓药物方案,并全程监控治疗药物,就不合理用药提出警示.结果 患者明显好转,住院及出院随访期间未发生不良事件.结论 临床药师的参与有助于精细化管理患者的药物治疗方案,并及时纠正不合理用药,更好的为患者服务.

Abstract

OBJECTIVE The antithrombotic plan after the complex treatment plan was sorted out,the an-tithrombotic drugs and the course of treatment were reformed to correct irrational drug use and promote rational drug use.METHODS Clinical pharmacists were involved in a case of heart failure,implantation of multiple stents for myocardial infarction for many times,combined with atrial fibrillation,performed radiofrequency ablation and left atri-al appendage occlusion,reformed the antithrombotic drug regimen,and monitored the treatment drugs throughout the whole process to warn against unreasonable drug use.RESULTS The patient improved significantly,and no adverse events occurred during hospitalization and discharge follow-up.CONCLUSION The participation of clinical phar-macists is helpful to fine management of drug treatment plan for patients,timely correction of unreasonable drug use,and better service for patients.

关键词

心力衰竭/心肌梗死/PCI支架植入术/直接口服抗凝药物(DOAC,Direct/oral/anticoagulants)/利伐沙班/新活素(注射用重组人脑利钠肽)/沙库巴曲缬沙坦

Key words

Heartfailure/Myocardial infarction/PCI stent implantation/Direct oral anticoagulants(DOAC)/Rivaroxaban/Neoplasin(recombinant human brain natriuretic peptide for injection)/Sacubitril Valsartan Sodium Tablets

引用本文复制引用

基金项目

兰州大学第一医院院内基金(ldyyyn2021-113)

出版年

2024
海峡药学
中国药学会福建分会

海峡药学

影响因子:0.643
ISSN:1006-3765
参考文献量17
段落导航相关论文